KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Non-Current Liabilities: 2012-2024

Historic Total Non-Current Liabilities for TherapeuticsMD (TXMD) over the last 6 years, with Dec 2024 value amounting to $10.7 million.

  • TherapeuticsMD's Total Non-Current Liabilities fell 11.89% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 11.89%. This contributed to the annual value of $10.7 million for FY2024, which is 20.01% down from last year.
  • TherapeuticsMD's Total Non-Current Liabilities amounted to $10.7 million in FY2024, which was down 20.01% from $13.4 million recorded in FY2023.
  • TherapeuticsMD's 5-year Total Non-Current Liabilities high stood at $261.0 million for FY2021, and its period low was $10.7 million during FY2024.
  • In the last 3 years, TherapeuticsMD's Total Non-Current Liabilities had a median value of $13.4 million in 2023 and averaged $26.1 million.
  • Data for TherapeuticsMD's Total Non-Current Liabilities shows a maximum YoY crashed of 79.23% (in 2022) over the last 5 years.
  • TherapeuticsMD's Total Non-Current Liabilities (Yearly) stood at $261.0 million in 2021, then slumped by 79.23% to $54.2 million in 2022, then slumped by 75.31% to $13.4 million in 2023, then declined by 20.01% to $10.7 million in 2024.